Great Diamond Partners LLC increased its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 9.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,368 shares of the company’s stock after acquiring an additional 641 shares during the […]
Kercheville Advisors LLC purchased a new position in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 7,470 shares of the company’s stock, valued at approximately $1,011,000. Several other institutional investors and hedge funds have also recently […]
Pacific Wealth Strategies Group Inc. increased its holdings in AbbVie Inc. (NYSE:ABBV – Get Rating) by 14.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,795 shares of the company’s stock after acquiring an additional 1,393 shares during […]
Gulf International Bank UK Ltd reduced its holdings in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 17.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 289,031 shares of the company’s stock after selling 60,017 shares during the quarter. Gulf International Bank UK […]
Willis Johnson & Associates Inc. increased its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 13.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,336 shares of the company’s stock after acquiring an additional 281 shares during the period. Willis Johnson […]